Out of 4 analysts covering Surgical Care Affliates (NASDAQ:SCAI), 2 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 50% are positive. $49 is the highest target while $37 is the lowest. The $44.75 average target is 7.57% above today’s ($41.6) stock price. Surgical Care Affliates has been the topic of 7 analyst reports since September 16, 2015 according to StockzIntelligence Inc. JP Morgan initiated the stock on September 16 with “Neutral” rating. Below is a list of Surgical Care Affiliates Inc (NASDAQ:SCAI) latest ratings and price target changes.
About 151,277 shares traded hands. Surgical Care Affiliates Inc (NASDAQ:SCAI) has risen 10.60% since February 8, 2016 and is uptrending. It has underperformed by 5.88% the S&P500.
Surgical Care Affiliates, Inc. is a well-known provider of solutions to physicians and health systems. The company has a market cap of $1.66 billion. The Firm operates a network of outpatient surgery facilities in the United States, which consists of over 190 ambulatory surgery centers (ASCs) and approximately seven surgical hospitals. It has a 13.38 P/E ratio. The Company’s network of facilities includes ASCs, surgical hospitals and hospital surgery departments.
The institutional sentiment decreased to 1.16 in 2016 Q2. Its down 0.53, from 1.69 in 2016Q1. The ratio fall, as 14 funds sold all Surgical Care Affiliates Inc shares owned while 50 reduced positions. 20 funds bought stakes while 54 increased positions. They now own 40.77 million shares or 0.03% less from 40.78 million shares in 2016Q1.
Tpg Group Holdings (Sbs) Advisors Inc. holds 6.37% of its portfolio in Surgical Care Affiliates Inc for 12.16 million shares. Welch Capital Partners Llc Ny owns 138,311 shares or 2.37% of their US portfolio. Moreover, Sivik Global Healthcare Llc has 1.66% invested in the company for 70,000 shares. The Connecticut-based Pier Capital Llc has invested 1.01% in the stock. Spark Investment Management Llc, a New York-based fund reported 225,900 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.